Category Archives: Patent Eligible Subject Matter

BIO Press Release

Posted on March 31, 2010 by Warren Woessner

For Immediate Release   www.bio.org  Contact: Stephanie Fischer     (202) 312-9263 or sfischer@bio.org BIO Statement on Initial Decision in Myriad Genetics Lawsuit Washington, D.C. (March 30, 2010) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

Myriad Ruling: DNA Sequences Are Unpatentable “ Products Of Nature”

Posted on March 30, 2010 by Warren Woessner

In a lengthy opinion released yesterday in Assoc. for Molec. Pathology v. USPTO, __F.Supp.2d___(S.D. N.Y.) (PDF below), the court invalidated claims directed to isolated DNA sequences, as well as to cancer screening methods using them, and even to methods of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

BIO Joins Stakeholders in Expressing Concerns with Efforts to Restrict Gene Patenting

Posted on February 5, 2010 by Warren Woessner

Today, the Secretary’s Advisory Committee on Genetics Health and Society (SACGHS), approved, with on dissent, a draft report which recommends legislative changes to the patent laws in regards to gene patents and recommends restrictions on licensing of federally funded research. … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , | Leave a comment

SACGHS Final Report on Gene Patents – Taking a Machete to the IP Thicket

Posted on February 5, 2010 by Warren Woessner

On September 17, 2009, the Secretary of HHS’s Advisory Committee on Genetics, Health and Society (SACGHS) issued a Final Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. The 66 page report … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment